Omar Turk
Neurology · Fort Gratiot, MINPI 1407824634
Payments from drug & device makers
Across 104 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$371
- Pfizer$228
- AbbVie$194
- Sanofi$162
- SK Life Science, Inc.$126
- Si-bone, Inc.$114
- plus $729 from 21 others
What the payments were for
- Food & beverage$1,924100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 30 | $371 |
| Pfizer | 14 | $228 |
| AbbVie | 5 | $194 |
| Sanofi | 9 | $162 |
| SK Life Science, Inc. | 5 | $126 |
| Si-bone, Inc. | 2 | $114 |
| Argenx US, Inc. | 3 | $71 |
| Teva Pharmaceuticals USA, Inc. | 4 | $62 |
| Kyowa Kirin, Inc. | 3 | $54 |
| Lilly USA, LLC | 4 | $53 |
| Amgen(2 entities) | 3 | $51 |
| Biogen | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Novartis | 2 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Eisai Inc. | 1 | $35 |
| Adamas Pharmaceuticals, Inc. | 2 | $32 |
| Bristol Myers Squibb | 2 | $31 |
| AstraZeneca | 1 | $26 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Boston Scientific | 1 | $15 |
| Neurelis, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,924 in reported general payments places this provider in the 55th percentile of 652 neurology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,648 | $32,907 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 649 | $13,182 |
| Gabapentin | 342 | $2,539 |
| Naloxone Hcl | 32 | $2,245 |
| Levetiracetam | 70 | $1,910 |
| Oxycodone Hcl | 108 | $1,641 |
| Morphine Sulfate | 45 | $1,336 |
| Pregabalin | 178 | $1,143 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 30 | $674 |
| Divalproex Sodium ErDivalproex Sodium | 12 | $482 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 32 | $468 |
| Tramadol Hcl | 107 | $404 |
| Ibuprofen | 78 | $397 |
| Butalbital-AcetaminophenButalbital/Acetaminophen | 15 | $329 |
| Ropinirole Hcl | 34 | $323 |
Paid to pharmacies, not to this prescriber.
Other neurology in Fort Gratiot
- Aaron EllenbogenFarmington Hills$14.5M
- Martin BelkinFarmington Hills$5.8M
- Evanthia BernitsasDetroit$4.8M
- Yang Mao DraayerFarmington Hills$4.2M
- Mirela CerghetDetroit$3.8M
- Peter le WittWest Bloomfield$3.2M
- Judith HeidebrinkAnn Arbor$2.2M
- Denise LeungAnn Arbor$2M
- Rany AburashedOwosso$1.9M
- Jeanie CoteOwosso$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.